CTG studies yield results. AIDS Clinical Trials Group

NIAID AIDS Agenda. Spring 1995;8-9.

Abstract

AIDS: NIAID's AIDS Clinical Trials Group (ACTG) has completed several studies and their findings are reported. Findings from two studies, ACTG 081, involving three therapies for pneumonia prevention, and ACTG 981, examining fluconazole for preventing fungal infections, are reported in The New England Journal of Medicine (March 16, 1995). Other studies reviewed include ACTG 152, using AZT alone and in combination in children, and ACTG 204, examining the effectiveness of valacyclovir and two different doses of acyclovir in preventing cytomegalovirus end stage-organ disease and survival extension.

Publication types

  • Newspaper Article

MeSH terms

  • Acyclovir / therapeutic use
  • Child
  • Clinical Trials as Topic
  • Cytomegalovirus Infections / complications
  • Cytomegalovirus Infections / drug therapy
  • Didanosine / administration & dosage
  • Didanosine / therapeutic use
  • Drug Therapy, Combination
  • Fluconazole / therapeutic use
  • HIV Infections / complications*
  • Humans
  • Mycoses / complications
  • Mycoses / prevention & control
  • Pneumonia, Pneumocystis / complications
  • Pneumonia, Pneumocystis / prevention & control*
  • Valacyclovir
  • Valine / analogs & derivatives
  • Valine / therapeutic use
  • Zidovudine / administration & dosage
  • Zidovudine / therapeutic use

Substances

  • Zidovudine
  • Fluconazole
  • Valine
  • Didanosine
  • Valacyclovir
  • Acyclovir